Related Experiment Videos
Immunogenicity of virus-induced rat osteosarcoma
The Journal of Bone and Joint Surgery. American Volume
|April 1, 1976
Summary
This study investigated virus-induced osteosarcoma immunogenicity in rats. Progressor rats showed blocked cell-mediated immunity, while regressors did not, indicating distinct immune responses to osteosarcoma.
Area of Science:
- Immunology
- Oncology
- Virology
Background:
- Osteosarcoma is a primary bone cancer.
- Viral oncogenesis can induce tumor development.
- Immune responses to tumors are complex.
Purpose of the Study:
- To investigate the immunogenicity of virus-induced rat osteosarcoma.
- To compare immune cell activity in tumor progressors versus regressors.
- To analyze the role of serum factors in modulating anti-tumor immunity.
Main Methods:
- Induction of osteosarcoma in rats using Moloney murine sarcoma virus.
- Lymphocyte microcytotoxicity assays to quantify cell-mediated cytotoxicity.
- Serum blocking assays to assess humoral immune interference.
Main Results:
- Tumors developed in 73% of rats, metastasizing to the lungs (progressors).
- Progressor lymphocytes killed osteosarcoma cells, but serum blocked this activity.
- Regressor animals showed tumor regression; their serum did not block lymphocyte activity.
- Both groups had humoral cytotoxic antibodies against tumor antigens.
Conclusions:
- Serum factors can abrogate anti-tumor cell-mediated immunity in progressor rats.
- Distinct immune profiles exist between rats with progressing versus regressing osteosarcoma.
- Humoral immunity plays a role in the host response to viral osteosarcoma.